JP2020514417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514417A5 JP2020514417A5 JP2019572349A JP2019572349A JP2020514417A5 JP 2020514417 A5 JP2020514417 A5 JP 2020514417A5 JP 2019572349 A JP2019572349 A JP 2019572349A JP 2019572349 A JP2019572349 A JP 2019572349A JP 2020514417 A5 JP2020514417 A5 JP 2020514417A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound
- compound according
- equations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000001475 halogen functional group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 230000003115 biocidal effect Effects 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 241000589291 Acinetobacter Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 150000003457 sulfones Chemical class 0.000 claims 2
- 150000003462 sulfoxides Chemical class 0.000 claims 2
- 150000003573 thiols Chemical class 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- -1 nitro, hydroxyl Chemical group 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 0 C=*C(*I=C1)*1=C Chemical compound C=*C(*I=C1)*1=C 0.000 description 1
- XSYNSKWOSDZKKN-UHFFFAOYSA-N CC(c1cnc(N)[nH]1)=C Chemical compound CC(c1cnc(N)[nH]1)=C XSYNSKWOSDZKKN-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762471464P | 2017-03-15 | 2017-03-15 | |
| US62/471,464 | 2017-03-15 | ||
| PCT/US2018/021474 WO2018169752A1 (en) | 2017-03-15 | 2018-03-08 | 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020514417A JP2020514417A (ja) | 2020-05-21 |
| JP2020514417A5 true JP2020514417A5 (enExample) | 2021-05-20 |
Family
ID=63523238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572349A Pending JP2020514417A (ja) | 2017-03-15 | 2018-03-08 | 微生物増殖の抑制に有用な２−アミノイミダゾール−フェニル誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11582970B2 (enExample) |
| EP (1) | EP3595446A4 (enExample) |
| JP (1) | JP2020514417A (enExample) |
| KR (1) | KR20190129072A (enExample) |
| CN (1) | CN110740645A (enExample) |
| AU (1) | AU2018234479A1 (enExample) |
| BR (1) | BR112019018770A2 (enExample) |
| CA (1) | CA3055558A1 (enExample) |
| RU (1) | RU2019132671A (enExample) |
| WO (1) | WO2018169752A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3927711A4 (en) * | 2019-02-22 | 2022-11-16 | Anifera Limited | COMPOSITIONS WITH IMPROVED ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA AND THEIR USE |
| US20230286922A1 (en) * | 2020-06-15 | 2023-09-14 | University Of Notre Dame Du Lac | Antibiotic adjuvant compounds |
| WO2024092149A1 (en) * | 2022-10-26 | 2024-05-02 | University Of Notre Dame Du Lac | Urea-linked 2-aminoimidazole dimer potentiators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007022947A2 (de) * | 2005-08-21 | 2007-03-01 | Abbott Gmbh & Co. Kg | 5-ring-heteroaromaten-verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| US7906544B2 (en) | 2007-01-26 | 2011-03-15 | North Carolina State University | Inhibition of bacterial biofilms with imidazole derivatives |
| WO2009145829A1 (en) * | 2008-04-01 | 2009-12-03 | University Of Massachusetts | Type iii secretion inhibitors, analogs and uses thereof |
| US9005643B2 (en) * | 2008-04-04 | 2015-04-14 | North Carolina State University | Inhibition of bacterial biofilms with imidazole-phenyl derivatives |
| US7897631B2 (en) | 2008-04-21 | 2011-03-01 | North Carolina State University | Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| EP2686317A4 (en) * | 2011-03-17 | 2014-08-20 | Selexagen Therapeutics Inc | RAF KINASE INHIBITORS |
| WO2012135016A2 (en) | 2011-03-25 | 2012-10-04 | North Carolina State University | Inhibition of bacterial biofilms and microbial growth with imidazole derivatives |
| US8840912B2 (en) | 2012-01-09 | 2014-09-23 | North Carolina State University | Imidazole derivatives useful for controlling microbial growth |
| EP3927711A4 (en) * | 2019-02-22 | 2022-11-16 | Anifera Limited | COMPOSITIONS WITH IMPROVED ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA AND THEIR USE |
-
2018
- 2018-03-08 EP EP18767442.9A patent/EP3595446A4/en not_active Withdrawn
- 2018-03-08 US US16/492,722 patent/US11582970B2/en active Active
- 2018-03-08 JP JP2019572349A patent/JP2020514417A/ja active Pending
- 2018-03-08 CN CN201880032076.9A patent/CN110740645A/zh active Pending
- 2018-03-08 AU AU2018234479A patent/AU2018234479A1/en not_active Abandoned
- 2018-03-08 CA CA3055558A patent/CA3055558A1/en not_active Abandoned
- 2018-03-08 RU RU2019132671A patent/RU2019132671A/ru not_active Application Discontinuation
- 2018-03-08 KR KR1020197029443A patent/KR20190129072A/ko not_active Ceased
- 2018-03-08 BR BR112019018770A patent/BR112019018770A2/pt not_active Application Discontinuation
- 2018-03-08 WO PCT/US2018/021474 patent/WO2018169752A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514417A5 (enExample) | ||
| JP2013541514A5 (enExample) | ||
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| ZA200406938B (en) | Novel florfenicol-type antibiotics. | |
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| IL165715A (en) | 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| WO2020061375A8 (en) | Antibacterial compounds | |
| WO2018208987A3 (en) | Antibacterial compounds | |
| EA200970534A1 (ru) | Антибактериальные производные хинолина | |
| WO2012134184A3 (ko) | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 | |
| EP4272831A3 (en) | Diazabicyclooctanones as inhibitors of serine beta-lactamases | |
| JP2018523675A5 (enExample) | ||
| MX385203B (es) | Compuestos y métodos para tratar infecciones bacterianas. | |
| IL87144A (en) | Pharmaceutical preparations containing naphthyridine carboxylic acids and process | |
| RU2019132671A (ru) | Производные 2-аминоимидазол-фенила, применимые для контроля роста микроорганизмов | |
| JP2024009968A5 (enExample) | ||
| CN107106533B (zh) | 用于治疗微生物感染的增效组合物 | |
| EP3737664B8 (en) | Antimicrobial 2-[[(phenyl)imino]methyl]-4-nitro-phenol derivatives and related compounds as inhibitors of the nusb-nuse interaction of microorganisms for the treatment of bacterial infections | |
| DE602005023492D1 (de) | 2-arylmethylazetidincarbapenemderivate und deren herstellung | |
| CH642850A5 (it) | Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi. | |
| RU2428419C2 (ru) | Новые бензофуроксаны, обладающие фунгицидной и бактерицидной активностью | |
| EA200970537A1 (ru) | Антибактериальные производные хинолина | |
| IL315304A (en) | Broad spectrum aminoglycosides and uses thereof | |
| JP2020506201A5 (enExample) | ||
| Neu et al. | In vitro studies of cephanone, a 3-heterocyclic-thiomethyl cephalosporin derivative |